Express Pharma

Lilly partners with API to launch a CME for obesity

The Obesity Gurukul program will aim to offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities

0 220

Eli Lilly and Company (India), in collaboration with the Association of Physicians of India (API), today announced the launch of ‘API – Obesity Gurukul’, a Continuing Medical Education (CME) program aimed at enhancing physicians’ clinical capabilities to address obesity, which is rapidly emerging as one of India’s most pressing public health challenges.

The program will aim to offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities. Through a combination of in-person educational sessions conducted by API state chapters and interactive online modules, the initiative will provide practical insights into the understanding of obesity pathophysiology and its management.

“Obesity is a complex, chronic condition that requires more than just treatment—it demands continuous medical education, empathy, and coordinated action across the healthcare ecosystem,” said Dr Manish Mistry, Senior Medical Director, Eli Lilly and Company (India). “By equipping physicians with the latest scientific insights and best practices, we aim to strengthen the quality of care and support better outcomes for people living with obesity.” 

Commenting on the partnership, Dr Jyotimoy Pal, President, API, said, “Obesity is no longer a lifestyle issue—it is a disease with deep clinical, psychological, and economic impact. The Obesity Gurukul program is an important step toward empowering physicians to recognise and treat obesity as a chronic condition.” 

In India, close to 100 million people are living with obesity, with an adult prevalence rate of approximately 6.5 per cent in 2023 (1). People with obesity deserve the same level of medical attention as those living with other chronic diseases, including access to efficient and evidence-based long-term care.

 

References 

  1. IQVIA analysis and projection based on National Family Health Survey (NFHS-5), India, 2019-20 and Data from Global Observatory (World Obesity) -https:// data.worldobesity.org/country/india-95/#data_economic-impact

 

Leave A Reply

Your email address will not be published.